Business Wire · AMLX · November 14, 2026

Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting

Get the app for more

Explore stock news, insights and company research.